“We had an excellent first quarter. We are seeing strong top-line growth and margin expansion resulting from increased interest in new and innovative tests, and from our focus on enhancing the overall experience for patients and physicians. We continue to see opportunities to grow our business profitably, and have increased our outlook for 2006.”
